OR WAIT null SECS
May 18, 2023
Biotech firm Lumen Bioscience has received fast track designation from FDA for its oral biologic drug candidate for treating C. difficile infection.
Gilead Sciences and Arcus Biosciences have expanded their research collaboration to include inflammatory diseases in addition to oncology.
May 17, 2023
Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.
Avirmax’s new gene therapy facility in Hayward, Calif., will specialize in AAV gene therapy research and development.
May 16, 2023
Under the collaboration, BiOneCure Therapeutics and Nanjing Leads Biolabs intend to develop a range of innovative antibody-drug conjugates for treating solid tumors.
May 12, 2023
In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
May 10, 2023
Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.
May 08, 2023
FDA’s Division of Applied Regulatory Science’s (DARS) computational toxicology and pharmacology research has been focused on the development of highly curated data sets and QSAR models for endpoints of regulatory interest.
May 02, 2023
New therapeutic opportunities are offering significant promise for the bio/pharma industry and patients.